ATI Stock Analysis: Allegheny Technologies | NYSE
Metal Fabrication | NYSE, USA | Market Cap: 24.281m USD | 12M Return: 147.8% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 257M
EPS Trend: 95.9%
Qual. Beats: 3
Rev. Trend: 97.6%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
ATI Inc. is a global producer of specialty materials and complex components operating through two segments: High Performance Materials & Components, and Advanced Alloys & Solutions. Its product portfolio spans titanium and titanium-based alloys, nickel- and cobalt-based superalloys, advanced powder alloys, zirconium and related alloys (including hafnium and niobium), and specialty steel products offered in long forms (ingot, billet, bar, rod, wire) as well as flat forms (plate, sheet, precision rolled strip), alongside precision forgings and machined parts.
ATI serves a diverse set of end markets including aerospace and defense, medical, oil and gas, automotive, construction and mining, transportation, and food equipment and appliances. The company also provides hot-rolling conversion services for carbon steel products. Founded in 1996 and headquartered in Dallas, Texas, ATI was formerly known as Allegheny Technologies Incorporated.
Although classified under the GICS Steel sub-industry, ATIs business model is closer to that of a specialty alloys producer than a commodity steelmaker, with significant exposure to high-specification materials used in demanding applications such as jet engines, airframes, and medical implants. Its reliance on titanium and nickel-based superalloys ties its revenue cycle closely to aerospace and defense build rates, which are typically long-cycle and backstopped by multi-year OEM agreements.
- Aerospace titanium demand rises with Boeing and Airbus production rates
- Jet engine superalloy margins expand on OEM long-term agreements
- Defense spending lifts titanium and specialty alloy order book
| Net Income: 425.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 6.95 > 1.0 |
| NWC/Revenue: 38.20% < 20% (prev 39.04%; Δ -0.84% < -1%) |
| CFO/TA 0.16 > 3% & CFO 835.0m > Net Income 425.5m |
| Net Debt (1.43b) to EBITDA (809.0m): 1.76 < 3 |
| Current Ratio: 2.67 > 1.5 & < 3 |
| Outstanding Shares: last quarter (139.4m) vs 12m ago -3.33% < -2% |
| Gross Margin: 22.53% > 18% (prev 21.38%; Δ 1.15% > 0.5%) |
| Asset Turnover: 88.20% > 50% (prev 86.10%; Δ 2.10% > 0%) |
| Interest Coverage Ratio: 6.41 > 6 (EBIT TTM 636.7m / Interest Expense TTM 99.3m) |
| A: 0.34 (Total Current Assets 2.80b - Total Current Liabilities 1.05b) / Total Assets 5.23b |
| B: 0.11 (Retained Earnings 586.9m / Total Assets 5.23b) |
| C: 0.12 (EBIT TTM 636.7m / Avg Total Assets 5.21b) |
| D: 0.53 (Book Value of Equity 1.77b / Total Liabilities 3.35b) |
| Altman-Z'' = 3.94 = AA |
| DSRI: 0.77 (Receivables 727.5m/912.9m, Revenue 4.59b/4.46b) |
| GMI: 0.95 (GM 21.38% / 22.53%) |
| AQI: 0.92 (AQ_t 0.09 / AQ_t-1 0.10) |
| SGI: 1.03 (Revenue 4.59b / 4.46b) |
| TATA: -0.08 (NI 425.5m - CFO 835.0m) / TA 5.23b) |
| Beneish M = -3.29 (Cap -4..+1) = AA |
As of August 03, 2026, the stock is trading at USD 187.44 with a total of 880,081 shares traded. Over the past week, the price has changed by -5.24%, over one month by -0.35%, over three months by +21.80% and over the past year by +147.81%.
Current recommended Stop Loss: 172.50 (which is 8% or 1.7 ATR below the current price).
Allegheny Technologies has received a consensus analysts rating of 4.45. Therefore, it is recommended to buy ATI.
- StrongBuy: 7
- Buy: 2
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 200.3 | 6.9% |
P/E Trailing = 58.7195
P/E Forward = 43.29
P/S = 5.2848
P/B = 14.4132
P/EG = 1.1952
Revenue TTM = 4.59b USD
EBIT TTM = 636.7m USD
EBITDA TTM = 809.0m USD
Long Term Debt = 1.79b USD (from longTermDebt, last quarter)
Short Term Debt = 33.2m USD (from shortTermDebt, last quarter)
Debt = 1.83b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.43b USD (calculated: Debt 1.83b - CCE 401.7m)
Enterprise Value = 25.7b USD (24.3b + Debt 1.83b - CCE 401.7m)
Interest Coverage Ratio = 6.41 (Ebit TTM 636.7m / Interest Expense TTM 99.3m)
EV/FCF = 46.53x (Enterprise Value 25.7b / FCF TTM 552.5m)
FCF Yield = 2.15% (FCF TTM 552.5m / Enterprise Value 25.7b)
FCF Margin = 12.03% (FCF TTM 552.5m / Revenue TTM 4.59b)
Net Margin = 9.26% (Net Income TTM 425.5m / Revenue TTM 4.59b)
Gross Margin = 22.53% ((Revenue TTM 4.59b - Cost of Revenue TTM 3.56b) / Revenue TTM)
Gross Margin QoQ = 22.83% (prev 23.21%)
Tobins Q-Ratio = 4.91 (Enterprise Value 25.7b / Total Assets 5.23b)
Interest Expense / Debt = 5.43% (Interest Expense 99.3m / Debt 1.83b)
Taxrate = 18.38% (98.8m / 537.4m)
NOPAT = 519.6m (EBIT 636.7m * (1 - 18.38%))
Current Ratio = 2.67 (Total Current Assets 2.80b / Total Current Liabilities 1.05b)
Debt / Equity = 1.03 (Debt 1.83b / totalStockholderEquity, last quarter 1.77b)
Debt / EBITDA = 1.76 (Net Debt 1.43b / EBITDA 809.0m)
Debt / FCF = 2.58 (Net Debt 1.43b / FCF TTM 552.5m)
Total Stockholder Equity = 1.76b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.17% (Net Income 425.5m / Total Assets 5.23b)
RoE = 24.23% (Net Income TTM 425.5m / Total Stockholder Equity 1.76b)
RoCE = 17.93% (EBIT 636.7m / Capital Employed (Equity 1.76b + L.T.Debt 1.79b))
RoIC = 13.03% (NOPAT 519.6m / Invested Capital 3.99b)
WACC = 11.80% (E(24.3b)/V(26.1b) * Re(12.35%) + D(1.83b)/V(26.1b) * Rd(5.43%) * (1-Tc(0.18)))
Discount Rate = 12.35% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -98.13 | Cagr: -3.03%
[DCF] Terminal Value 67.66% ; FCFF base≈406.3m ; Y1≈465.7m ; Y5≈685.4m
[DCF] Fair Price = 36.42 (EV 6.40b - Net Debt 1.43b = Equity 4.97b / Shares 136.5m; r=11.80% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 95.87 | EPS CAGR: 20.04% | SUE: 1.48 | # QB: 3
Revenue Correlation: 97.64 | Revenue CAGR: 4.83% | SUE: -0.57 | # QB: 0
EPS current Quarter (2026-06-30): EPS=1.04 | Chg30d=+2.07% | Revisions=+62% | Analysts=7
EPS next Quarter (2026-09-30): EPS=1.15 | Chg30d=+1.12% | Revisions=+38% | Analysts=6
EPS current Year (2026-12-31): EPS=4.46 | Chg30d=+0.68% | Revisions=+25% | GrowthEPS=+37.5% | GrowthRev=+8.5%
EPS next Year (2027-12-31): EPS=5.42 | Chg30d=+0.27% | Revisions=+25% | GrowthEPS=+21.6% | GrowthRev=+9.7%
[Analyst] Revisions Ratio: +67% (up=11, down=1)